Effect of NO inhibitors on hypovolemic shock-induced hypotension. 2010

S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
Medical Radiology Research Center, Russian Academy of Medical Sciences, Obninsk, Russia. pros@mrrc.obninsk.ru

In vivo effect of isothiourea derivatives on NO production was studied by the method of electron paramagnetic resonance spectroscopy with a spin trap. We evaluated the influence of these compounds on hemodynamic parameters in anesthetized rats with hypovolemic shock. A correlation was found between the size of S,N-substituents in isothiourea derivatives (methyl, ethyl, and isopropyl) and NO inhibitory activity of compounds. The antihypotensive effect was more pronounced in compounds with high NO inhibitory activity containing the isopropyl radical.

UI MeSH Term Description Entries
D007022 Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. Blood Pressure, Low,Hypotension, Vascular,Low Blood Pressure,Vascular Hypotension
D008297 Male Males
D004578 Electron Spin Resonance Spectroscopy A technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons. The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. (From McGraw-Hill Encyclopedia of Science and Technology, 7th edition) Electron nuclear double resonance (ENDOR) spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications such as MAGNETIC RESONANCE IMAGING. ENDOR,Electron Nuclear Double Resonance,Electron Paramagnetic Resonance,Paramagnetic Resonance,Electron Spin Resonance,Paramagnetic Resonance, Electron,Resonance, Electron Paramagnetic,Resonance, Electron Spin,Resonance, Paramagnetic
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D012769 Shock A pathological condition manifested by failure to perfuse or oxygenate vital organs. Circulatory Collapse,Circulatory Failure,Hypovolemic Shock,Collapse, Circulatory,Failure, Circulatory,Shock, Hypovolemic
D013890 Thiourea A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS.
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
September 1965, American journal of surgery,
S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
December 1986, International journal of pancreatology : official journal of the International Association of Pancreatology,
S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
January 1979, Urologic radiology,
S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
May 2009, AJR. American journal of roentgenology,
S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
July 1955, The American journal of physiology,
S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
January 1988, Brain & development,
S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
January 1977, Haemostasis,
S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
January 1981, Circulatory shock,
S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
January 1991, Lancet (London, England),
S Ya Proskurjakov, and M V Filimonova, and O N Borovaya, and N G Kucherenko, and A I Trishkina, and L V Shteyn, and V G Skvortsov, and L P Ul'yanova, and L I Shevchenko, and Yu G Verkhovsky
January 1967, Anesthesia and analgesia,
Copied contents to your clipboard!